DNA “fingerprints” offer new answers to mental disorders
en-GBde-DEes-ESfr-FR

DNA “fingerprints” offer new answers to mental disorders


Mental disorders, such as obsessive-compulsive disorder (OCD) and bipolar disorder, can strongly affect daily life. They are usually caused by a mix of genetic risk and environmental factors like stress or adverse life events. But understanding how these influences work together has been a major challenge.

Epigenetics helps explain this link. It refers to chemical changes that affect how genes work, without changing the DNA sequence itself.

One key mechanism is DNA methylation — small chemical “marks” that can be influenced by both our genes and our experiences, especially early in life.

Clear differences in patients

In two new studies, researchers from the University of Bergen compared DNA methylation patterns in people with either OCD or bipolar disorder to those of healthy controls. The studies have been published in Biological Psychiatry and Lancet eBiomedicine, respectively.

They found clear differences between the groups.

Many of these changes were linked to genes involved the immune system, suggesting that immune processes may play an important role in both disorders. Other genes implicated were relevant to neuronal functions and were relevant for the respective disorders.

Importantly, some of the DNA changes overlapped with known genetic risk factors, which may help explain how genetic risk may increase the disease liability. Others were independent of genetics, likely reflecting the impact of environmental factors such as stress.

In bipolar disorder, researchers showed that a global “methylation score” could improve prediction models when added to genetic information—an important step toward precision psychiatry.

A growing research tool

Together, the findings show that epigenetic research is becoming a powerful addition to genetic studies in psychiatry.

While larger studies are still needed, international collaboration is already making it possible to uncover new biological insights, and move closer to more tailored treatments for mental disorders.

Links to the publications:
www.biologicalpsychiatryjournal.com/article/S0006-3223(26)01133-9/fulltext

https://www.sciencedirect.com/science/article/pii/S2352396426001660

Archivos adjuntos
  • Markos Woldeyohannes, University of Bergen. Credit: A.Kibret, M.D.
  • Kira Daniela Höffler, University of Bergen. Credit: Lise Skarstein Jakobsen
  • Stéphanie Le Hellard, University of Bergen. Credit: Melanie Burford
Regions: Europe, Norway
Keywords: Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonios

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Trabajamos en estrecha colaboración con...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by DNN Corp Terms Of Use Privacy Statement